Article Details
Retrieved on: 2021-05-26 12:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Verseau's first-in-class monoclonal antibody candidates, VTX-0811 targeting PSGL-1 and VTX-1218 targeting VSIG4, are in late preclinical ...
Article found on: www.joplinglobe.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here